Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Ponting

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Scientific Reports|February 18, 2016
Peptide Reactivity of Isothiocyanates--Implications for Skin AllergyIsabella Karlsson, Kristin Samuelsson, David J Ponting, et al.
Regulatory Toxicology and Pharmacology : RTP|October 7, 2023
Nitrosamine acceptable intakes should consider variation in molecular weight: The implication of stoichiometric DNA damageJonathan Fine, Leonardo Allain, Joerg Schlingemann, et al.
Journal of Chemical Information and Modeling|May 2, 2020
Predicting p<i>K</i><sub>a</sub> Using a Combination of Semi-Empirical Quantum Mechanics and Radial Basis Function MethodsPeter Hunt, Layla Hosseini-Gerami, Tomas Chrien, et al.
Journal of Chemical Information and Modeling|May 25, 2023
Predicting Regioselectivity of Cytosolic Sulfotransferase Metabolism for DrugsMario Öeren, Sylvia C Kaempf, David J Ponting, et al.
Journal of Computer-Aided Molecular Design|June 14, 2020
Predicting reactivity to drug metabolism: beyond P450s-modelling FMOs and UGTsMario Öeren, Peter J Walton, Peter A Hunt, et al.
Archives of Toxicology|January 3, 2025
Critical comparison of BMD and TD<sub>50</sub> methods for the calculation of acceptable intakes for N-nitroso compoundsRobert Thomas, David J Ponting, Andrew Thresher, et al.
Regulatory Toxicology and Pharmacology : RTP|August 11, 2020
Are all nitrosamines concerning? A review of mutagenicity and carcinogenicity dataAndrew Thresher, Robert Foster, David J Ponting, et al.
Journal of Medicinal Chemistry|October 14, 2022
Predicting Regioselectivity of AO, CYP, FMO, and UGT Metabolism Using Quantum Mechanical Simulations and Machine LearningMario Öeren, Peter J Walton, James Suri, et al.
Regulatory Toxicology and Pharmacology : RTP|December 22, 2025
Establishing best practice for N-nitrosamine read-across and surrogate selectionDavid J Ponting, Gabriela de Oliveira Silveira, Philip Rowell, et al.
Clinical Pharmacology and Therapeutics|March 18, 2024
A Case to Support the Continued Use of Rifampin in Clinical Drug-Drug Interaction StudiesJoel P Bercu, David J Ponting, Sharon L Ripp, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Scientific Reports|February 18, 2016
Peptide Reactivity of Isothiocyanates--Implications for Skin AllergyIsabella Karlsson, Kristin Samuelsson, David J Ponting, et al.
Regulatory Toxicology and Pharmacology : RTP|October 7, 2023
Nitrosamine acceptable intakes should consider variation in molecular weight: The implication of stoichiometric DNA damageJonathan Fine, Leonardo Allain, Joerg Schlingemann, et al.
Journal of Chemical Information and Modeling|May 2, 2020
Predicting p<i>K</i><sub>a</sub> Using a Combination of Semi-Empirical Quantum Mechanics and Radial Basis Function MethodsPeter Hunt, Layla Hosseini-Gerami, Tomas Chrien, et al.
Journal of Chemical Information and Modeling|May 25, 2023
Predicting Regioselectivity of Cytosolic Sulfotransferase Metabolism for DrugsMario Öeren, Sylvia C Kaempf, David J Ponting, et al.
Journal of Computer-Aided Molecular Design|June 14, 2020
Predicting reactivity to drug metabolism: beyond P450s-modelling FMOs and UGTsMario Öeren, Peter J Walton, Peter A Hunt, et al.
Archives of Toxicology|January 3, 2025
Critical comparison of BMD and TD<sub>50</sub> methods for the calculation of acceptable intakes for N-nitroso compoundsRobert Thomas, David J Ponting, Andrew Thresher, et al.
Regulatory Toxicology and Pharmacology : RTP|August 11, 2020
Are all nitrosamines concerning? A review of mutagenicity and carcinogenicity dataAndrew Thresher, Robert Foster, David J Ponting, et al.
Journal of Medicinal Chemistry|October 14, 2022
Predicting Regioselectivity of AO, CYP, FMO, and UGT Metabolism Using Quantum Mechanical Simulations and Machine LearningMario Öeren, Peter J Walton, James Suri, et al.
Regulatory Toxicology and Pharmacology : RTP|December 22, 2025
Establishing best practice for N-nitrosamine read-across and surrogate selectionDavid J Ponting, Gabriela de Oliveira Silveira, Philip Rowell, et al.
Clinical Pharmacology and Therapeutics|March 18, 2024
A Case to Support the Continued Use of Rifampin in Clinical Drug-Drug Interaction StudiesJoel P Bercu, David J Ponting, Sharon L Ripp, et al.
Pageof 4